Table 1.
Baseline S. haematobium infection intensity and demographic characteristics of initial and post-treatment follow-up cohorts.
Figure 1.
IL-5 and IL-13 plasma levels pre and post-treatment by age.
Shown are the geometric mean plasma IL-5 and IL-13 levels and 95% confidence intervals, pre-treatment (dotted line) and 24-hours post-treatment (solid line) by age.
Table 2.
Linear regression model of the boost in levels of plasma IL-5.
Table 3.
Linear regression models of the boost in eosinophil number at 9 weeks post-treatment.
Figure 2.
SWA-IgE levels pre and post-treatment by age.
Shown are the geometric mean SWA-IgE levels and 95% confidence intervals, pre-treatment (dotted line) and 9-weeks post-treatment (solid line) by age.
Table 4.
Linear regression models of boost in SWA-IgE at 9 weeks post-treatment.
Table 5.
Logistic regression models of re-infection status.